Physician profile
Dane Langsjoen
NPI 1245597400
$4,711.90
in general payments reported to CMS, 2019-2025
21 companies · $1,407 in 2025
The $1,407 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2021: $286 · 2022: $769 · 2023: $999 · 2024: $1,132 · 2025: $1,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,537.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,263.18 | 2019-2025 | Assurity, Aveir, Gallant |
| Novartis Pharmaceuticals Corporation | $516.28 | 2019-2025 | |
| Stryker Corporation | $477.52 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Inari Medical, INC. | $296.64 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $288.94 | 2021-2025 | Farxiga, Andexxa |
| Boston Scientific Corporation | $288.04 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Valitude Crt-P, Emblem Mri S-Icd |
| Pfizer INC. | $244.61 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $206.61 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $195.12 | 2022-2025 | Camzyos, Eliquis |
| Amgen INC. | $188.99 | 2022-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $174.16 | 2023-2025 | Jardiance |
| Heartflow, INC. | $135.62 | 2021 | |
| Abiomed | $131.85 | 2022 | |
| Philips North America LLC | $71.72 | 2024-2025 | Extended Holter, (Ck7) Extended Holter |
| Irhythm Technologies, INC. | $66.10 | 2022-2024 | Zio Xt Patch, Zio Monitor |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $53.11 | 2025 | Corevalve Evolut R, Symplicity G3 |
| Kiniksa Pharmaceuticals International, Plc | $45.22 | 2024 | Arcalyst |
| Neuros Medical, INC. | $18.16 | 2025 | Altius |
| Biotronik INC. | $17.53 | 2022 | |
| Teleflex LLC | $17.35 | 2023 | Manta |
| Inspire Medical Systems, INC. | $15.15 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dane Langsjoen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.